Insmed. Every tracked FinTwit mention of $INSM, newest first. 18 mentions since the first on Sep 2, 2025. See the price chart.
July 2026 · 1 mention
Jul 6
Adam Feuerstein ✡️ — $CRNX is a commercial stage biotech that was significantly underperforming the $XBI this year, similar to $INSM $MDGL $ALNY $BBIO
Crinetics just acquired for a 100% premium by $V…↗
June 2026 · 2 mentions
Jun 12
The Future Investors — Nasdaq-100 Rebalance 📊
Nasdaq announced its quarterly index changes, effective June 22.
✅ Added: $ALAB, $CRWV, $NBIS, $RKLB, $TER
❌ Removed: $CHTR, $CTSH, $INSM, $VRSK, $ZS http…↗
Jun 12
unusual_whales — BREAKING: Nasdaq will add $ALAB, $CRWV, $NBIS, $RKLB, and $TER to the Nasdaq-100 effective June 22, 2026, while removing $CHTR, $CTSH, $INSM, $VRSK, and $ZS as part of its quarterl…↗
May 2026 · 3 mentions
May 19
Adam Feuerstein ✡️ — Good morning from SF. STAT’s #STATbreakthrough live event kicks off in a few hours. I’ll be chatting with $BBIO Neil Kumar and $INSM Will Lewis. Any questions? Drop them here. htt…↗
May 7
Adam Feuerstein ✡️ — Today is an opportune moment to mention STAT's next live event in San Francisco on May 19.
I will be chatting on stage with $INSM CEO Will Lewis and $BBIO CEO Neil Kumar.
Full…↗
May 7
Adam Feuerstein ✡️ — $INSM Q1 Brinsupri sales $208 million, above sell-side consensus but below the buyside "whisper" expectation that has moved around from the $2-teens to $220-ish.↗
March 2026 · 1 mention
Mar 23
Adam Feuerstein ✡️ — $INSM Insmed drug Arikayce benefits patients with rare, bacterial lung disease, study shows https://t.co/z7FPoZHxoP↗
February 2026 · 1 mention
Feb 19
Adam Feuerstein ✡️ — $INSM guides to 2026 Brinsupri sales of "at least $1B" in line with consensus.
https://t.co/o7JhPKU3m1↗
January 2026 · 3 mentions
Jan 12
Adam Feuerstein ✡️ — Insmed $INSM basks in the success of its lung disease drug — and prepares for what’s next. I chatted Sunday with CEO Will Lewis before watching the Patriots beat the Chargers. #JPM…↗
Jan 9
Adam Feuerstein ✡️ — $INSM pre-announces Q4 Brinspuri sales of $144.6M. Consensus $67M, per Visible Alpha.
Total '25 revenue $606.4 vs consensus $523M
2026 Arikayce revenue forecast $450-470M vs con…↗
Jan 6
InvestmentGuru — The Fastest Growing Companies Heading Into 2026
From AI infrastructure and space to biotech, energy, and digital assets, these companies are where real growth is showing up on the…↗
December 2025 · 3 mentions
Dec 30
Adam Feuerstein ✡️ — @WassimLaroussi3 @aggregategains Apologies for all these questions, but I’m curious if you also were turned off by my bullish $INSM stories and X posts? I don’t follow you here, so…↗
Dec 17
Adam Feuerstein ✡️ — $INSM stumble
Phase 2b BiRCh Study of Brensocatib in CRSsNP Did Not Meet Primary or Secondary Efficacy Endpoints; Safety Consistent with Previous Studies; Insmed Discontinues CRS…↗
Adam Feuerstein ✡️ — @Biohazard3737 I put together a Q4 list, fairly active heading into end of year, which is nice. Will post it later in the week.
$INSM $NKTR $GPCR $CYTK among others↗